DSP Global Funds ICAV (the “ICAV”) is an open-ended umbrella type Irish collective asset-management vehicle with variable capital and limited liability registered with and authorised by the Central Bank of Ireland to carry on business as an ICAV, pursuant to Part 2 of the Irish Collective Asset-management Vehicles Act, 2015 and established as an undertaking for collective investment in transferable securities with segregated liability between its Funds pursuant to the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations, 2011 (S.I. No. 352 of 2011) as amended. The ICAV is structured as an umbrella fund and each Funds represents a separate portfolio of assets and further sub-divided, to denote differing characteristics attributable to particular Shares, into Classes.
Investment Objective: The investment objective of the Fund is to achieve long term capital appreciation from a portfolio that is substantially constituted of equity and equity related securities of mid cap and small cap companies.
Investment Horizon: The Fund may be suitable for those investors with a medium to long term time horizon who wish to gain exposure to Indian equity markets and who recognize the risks of investing in an emerging market country and who can tolerate the level of volatility of returns typical of such an investment.
Investment Risks: Investment in the Fund involves certain risk factors and considerations relating to the Fund's structure and investment objective which a prospective investor should evaluate before making a decision to invest in the Fund. No assurance can be given that the Fund will succeed in meeting its investment objective or that there will be any return on capital. Moreover, past performance is not a guarantee of future results. Please refer the Section ‘Risk Factors’ provided in the Prospectus & Supplement for further details.
The DSP India Equity Fund (the “ICAV Fund”) aims to achieve long term capital appreciation from a portfolio that is substantially constituted of equity and equity related securities of mid cap and small cap companies.
Vinit Sambre is Head – Equities at DSP Investment Managers Private Limited (‘DSPIM’). Vinit specializes in the small and mid-cap space and has over 20 years of relevant work experience.
Vinit joined DSPIM in July 2007, as Portfolio Analyst for the firm's Portfolio Management Services (PMS) division, which manages discretionary accounts and provides advisory services to institutional clients. As a research analyst, his focus was on sectors like Pharmaceuticals, Power Utilities, Chemicals, Fertilizers and Textiles
Previously, he was with DSP Merrill Lynch as a part of its Global Private Client business. He spent 20 months at DSP Merrill Lynch as Equity Strategist. Prior to DSP Merrill Lynch, he was employed with IL&FS Investsmart Limited as an Equity Analyst in their PMS division. He has also worked with UTI Investment Advisory Services as Equity Analyst for the offshore fund – India Growth Fund. Vinit is a Chartered Accountant from Institute of Chartered Accountant of India. Currently he is Fund Manager of below schemes.
Denominated Currency: USD
Launch Date: 15-Mar-2021
|1 MONTH||1 YEAR||3 YEARS||5 YEARS||SINCE LAUNCH|
|DSP Representative Fund||-2.79%||-6.96%||7.85%||3.35%||9.59%|
|Benchmark (in USD)||-3.24%||-7.16%||14.67%||3.45%||6.10%|
|DSP Representative Fund||48.82%||-17.68%||6.86%||20.53%||25.84%||-11.60%|
|Benchmark (in USD)||61.34%||-22.24%||-2.21%||19.86%||46.15%||-12.33%|
Denominated Currency: USD
|Supreme Industries Limited||Industrial Products||India||4.46%|
|Alkem Laboratories Limited||Pharmaceuticals & Biotechnology||India||3.72%|
|The Phoenix Mills Limited||Realty||India||3.71%|
|The Federal Bank Limited||Banks||India||3.37%|
|IPCA Laboratories Limited||Pharmaceuticals & Biotechnology||India||3.35%|
|Bharat Forge Limited||Industrial Products||India||3.34%|
|Coromandel International Limited||Fertilizers & Agrochemicals||India||3.21%|
|Atul Limited||Chemicals & Petrochemicals||India||3.17%|
|Polycab India Limited||Industrial Products||India||3.16%|
|Emami Limited||Personal Products||India||2.92%|
|Pharmaceuticals & Biotechnology||8.91%|
|Chemicals & Petrochemicals||7.29%|
|Fertilizers & Agrochemicals||6.15%|
The key risks associated with investment in ICAV Fund/Sub-Fund(s) is summarised below. Potential subscribers/investors must refer to the Prospectus & Supplement for the detailed risks associated with investment in the Fund before investing.Different risks may apply to different Funds and/or Classes.